# Platelet and Immune Response in Covid-19 Vaccine

> **NCT05171959** · — · UNKNOWN · sponsor: **University of Roma La Sapienza** · enrollment: 32 (estimated)

## Conditions studied

- SARS-CoV-2 Vaccination

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05171959
- **Lead sponsor:** University of Roma La Sapienza
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-05-05
- **Primary completion:** 2022-02-15
- **Final completion:** 2022-04-15
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2021-12-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05171959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05171959, "Platelet and Immune Response in Covid-19 Vaccine". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05171959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*